FDA Guidance for Industry: Residual Solvents in Drug Products Marketed in the United States
Title:
FDA Guidance for Industry: Residual Solvents in Drug Products Marketed in the United States
Origin/Publisher:
FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070621.pdf
Content:
This guidance is intended to assist manufacturers in responding to the issuance of a new USP test requirement for the control of residual solvents in drug products marketed in the United States.